Athira Pharma (ATHA) Falls in Pre-Market Trading for June 22

Equities Staff  |

Athira Pharma Inc (NASDAQ:ATHA) has already dropped $-5.71 in early trading Wednesday.

After closing the previous trading session at $8.45, Athira Pharma has moved 67.57% lower ahead of market open.

The company has increased 5.23% over the last 5 days.

Today could shape up to be an interesting day for Athira Pharma investors.

For technical charts, analysis, and more on Athira Pharma Inc visit the company profile.

Pre-market prices and movements as of 08:21:27 est.

About Athira Pharma Inc

Athira, headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Athira aims to provide rapid cognitive improvement and alter the course of neurological diseases with its novel mechanism of action. Athira is currently advancing its lead therapeutic candidate, ATH-1017, a novel small molecule for Alzheimer’s and Parkinson’s dementia.

To get more information on Athira Pharma Inc and to follow the company's latest updates, you can visit the company's profile page here: Athira Pharma Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content